
Our Laboratory
Focuses on understanding the regulation of the inflammatory response at a molecular level, and elucidating how these events may participate in human disease.
Our work has identified specific pathways for the termination of NF-κB mediated transcription that involve the ubiquitination and proteasomal degradation of this transcription factor.